What is the rationale behind targeting angiogenesis in cancer therapy?

Inhibiting angiogenesis starves the tumor of nutrients, hindering its growth.

Angiogenesis inhibitors directly kill cancer cells.

Angiogenesis is unrelated to tumor growth.

Promoting angiogenesis enhances immune cell infiltration into the tumor.